Frequently
Asked
Questions

To improve or cure cancer using dendritic cells, the work mechanism is pretty much the same and effective in any cancer that forms tissue structures (tumours, carcinomas, melanomas, sarcomas etc.). This makes every cancer patient – including all cancer types that form a solid tumour or carcinoma, including metastasis – eligible apart from some forms of leukaemia. As the treatment effect is natural, it works in every stage of the cancer journey and it can be used in conjunction or separate from any other treatment. Oncologists with expertise in immunology will likely suggest dendritic cell therapy as a first and primary therapy. For clarity DCT, unlike chemotherapy, is a primary therapy, while most believe DCT is just an adjunctive therapy. To determine the best strategy, we are happy to discuss your individual situation based on your medical reports.

The majority of specialists are unaware of this therapy and it is not yet mainstream in treatment pathways. As with all new treatments, it takes time to convince a large part of the medical profession. The benefit this therapy has is that there is no harm done to the body, yet it has higher success rates than traditional treatments according to many clinical reports.

The treatment itself only takes around 2 weeks and the patient is only required for a blood draw and serum injection (approximately 9 days later). The immune system then works for a long period recognising the cancer cells.

DCT is a private treatment, even though a growing number of health insurances are covering the costs. Please request an individual proposal according to your health condition and accommodation preferences.

Choosing DCT as a minimally invasive and non-toxic first option does not limit or restrict the opportunity to have any other treatment afterwards if deemed necessary.

Dendritic cells need to be primed with cancerous material (e.g. antigens) that only exist in an affected body. The earlier the therapy is given, the easier it is for the immune system, to fight the cancer. On the other hand – even in terminal stages results may show prolonged life and improved quality of life dependant on the case. As well as a palliative treatment DCT might – if cure is no longer expected – reduce pain and enhance quality of life.

You can undertake a web research, find clinical studies on the cancer you are confronted with on our website or talk to our experts in English, German, Spanish and other languages. For your information, at the last count there were more than 70 000 medical publications on DCT (Dendritic Cell Therapy) and cancer.

This is dependent on individual cases.

Our doctors will guide you on changing your “biological terrain” to get you more alkaline, as well as toxin and stress free, thus eliminating the conditions where cancer thrives.

The treatment can take place either in one of Immucura’s partner clinics (in Germany, Gibraltar, Holland, etc.) or in any clinic located close to our patients’ homes. Furthermore, if the patient cannot travel, Immucura is able to send a medical team to the patient’s home. Thanks to the well-structured logistics network, Immucura can reach out to and help patients in many different countries, giving them access to this vanguard treatment.

The friendly staff at Immucura is always available for e-mail or telephone inquiries. You are also free to contact us in the form at the bottom of this page.